The deadline for application for INBIO Travel Grants has been extended until January 12, 2007!

INDOOR Biotechnologies will provide up to four $750 travel grants to enable graduate students, post-docs, allergy fellows or junior faculty to attend the American Academy of Allergy, Asthma, and Immunology Annual Meeting in San Diego, California, February 23-27, 2007. The application process is as follows:

• Applicants should indicate why it is important for them to attend AAAAI in a one page cover letter. Please indicate whether you have applied for travel grants from any other sources. Applicants should also submit:
• A brief (1-2 page) curriculum vitae
• Abstract of the work they are proposing to submit or which has been accepted for presentation.
• A supporting letter from the Head of Department confirming that attendance at the meeting is appropriate and authorized.

All of these items should be submitted in a single PDF file to Dr. Anna Pomes (apomes@inbio.com), to whom all enquiries should be addressed. The INDOOR Biotechnologies Travel Grant Program is competitive. We look forward to receiving your application!

INDOOR Biotechnologies will provide four $750 travel grants to enable graduate students, post-docs, allergy fellows or junior faculty to attend the American Academy of Allergy, Asthma, and Immunology Annual Meeting in San Diego, California, February 23-27, 2007. The deadline for submission is 31st December 2006 and the application process is as follows:

• Applicants should indicate why it is important for them to attend AAAAI in a one page cover letter. Please indicate whether you have applied for travel grants from any other sources. Applicants should also submit:
• A brief (1-2 page) curriculum vitae
• Abstract of the work they are proposing to submit or which has been accepted for presentation.
• A supporting letter from the Head of Department confirming that attendance at the meeting is appropriate and authorized.

All of these items should be submitted in a single PDF file to Dr. Anna Pomes (apomes@inbio.com), to whom all enquiries should be addressed. The INDOOR Biotechnologies Travel Grant Program is competitive. We look forward to receiving your application!

We are pleased to welcome Sandra Docherty as our new Business Manager at Indoor Biotechnologies Ltd. Sandra graduated with a BA in Business Studies (Hons.) and worked as a financial advisor in London with Alexanders and Noble Lowndes until 1996. Subsequently, she continued with academic studies in finance and communication skills and, while taking time out to bring up her son, worked in a quasi-judicial capacity for the Scottish Executive on the Children's Panel. After returning to the financial sector earlier this year, Sandra decided to pursue other opportunities and we are delighted that she has joined INDOOR Biotechnologies. Sandra brings new drive and enthusiasm to the position and is looking forward to developing business relationships and opportunities with all of our clients.
sandradocherty@indoorbiotech.co.uk

INDOOR BIOTECHNOLOGIES LTD
The Old Brewery
38, High Street
Warminster
Wiltshire, BA12 9AF
UNITED KINGDOM

TEL: 44 (0)5601 153 291
FAX: 44 (0)1985 218300
E-mail: info@indoorbiotech.co.uk

Results of the European Community Respiratory Health Survey (ECRHS) of mite and cat allergen exposure in 22 cities across Europe have just been published in the September edition of the Journal of Allergy and Clinical Immunology*. Over 3000 mattress dust samples were analyzed for mite allergens (Der p 1, Der f 1, Group 2) and for Fel d 1. Although mite allergens were detected in >50% of samples, there were large variations in allergen levels (GM <0.1 - 14.7ug/g Group 1 allergen) that were attributed to geographic and housing characteristics, with dampness and old mattresses being particularly associated with high allergen levels. The ECRHS data confirmed large variation in cat allergen levels among current and past cat owners (GM 1.8-207ug/g and 0.07-5.0ug/g, respectively). Not having a cat at home did not protect against community exposure to Fel d 1, particularly in communities with high levels of cat ownership. *Heinrich et al, JACI 118:674-81, 2006; Zoch et al JACI 118: 682-690, 2006.

Both papers carried a Memoriam to Dr. Christina Luczynska who sadly died in 2005. Christina developed the Der p 1 and Der f 1 allergen assays, and studied the aerodynamic properties of Fel d 1, as a post-doctoral fellow at the University of Virginia in the 1980's. (Luczynska et al, J Immunol Meths 118:227-35, 1989; Luczynska at al, Am Rev Respir Dis 141:361-7, 1990).